CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-08-16
DOI
10.3389/fimmu.2022.970950
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Afatinib alone and in combination with vinorelbine or paclitaxel, in patients with HER2-positive breast cancer who failed or progressed on prior trastuzumab and/or lapatinib (LUX-Breast 2): an open-label, multicenter, phase II trial
- (2022) Tamas Hickish et al. BREAST CANCER RESEARCH AND TREATMENT
- Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer
- (2022) Tianyi Cheng et al. Frontiers in Genetics
- Intelligent Biomimetic Nanoplatform for Systemic Treatment of Metastatic Triple-Negative Breast Cancer via Enhanced EGFR-Targeted Therapy and Immunotherapy
- (2022) Xiaoxi Wang et al. ACS Applied Materials & Interfaces
- ZNF703 promotes triple-negative breast cancer cells through cell-cycle signaling and associated with poor prognosis
- (2022) Xi Zhang et al. BMC CANCER
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Integrated Analysis Reveals Critical Ferroptosis Regulators and FTL Contribute to Cancer Progression in Hepatocellular Carcinoma
- (2022) Shaoying Ke et al. Frontiers in Genetics
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Breast cancer
- (2021) Sibylle Loibl et al. LANCET
- A network approach reveals driver genes associated with survival of patients with triple-negative breast cancer
- (2021) Courtney D. Dill et al. iScience
- Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer
- (2021) David Samuel Kereh et al. Breast Disease
- Ferroptosis-related gene signature predicts the prognosis of papillary thyroid carcinoma
- (2021) Jinyuan Shi et al. Cancer Cell International
- CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer
- (2021) Stanley I. Gutiontov et al. Scientific Reports
- Multi-Omics Analysis of Novel Signature for Immunotherapy Response and Tumor Microenvironment Regulation Patterns in Urothelial Cancer
- (2021) Guangdi Chu et al. Frontiers in Cell and Developmental Biology
- Ferroptosis: past, present and future
- (2020) Jie Li et al. Cell Death & Disease
- Disulfiram/Copper Induces Antitumor Activity against Both Nasopharyngeal Cancer Cells and Cancer-Associated Fibroblasts through ROS/MAPK and Ferroptosis Pathways
- (2020) Yiqiu Li et al. Cancers
- Genetic and epigenetic intratumor heterogeneity impacts prognosis of lung adenocarcinoma
- (2020) Xing Hua et al. Nature Communications
- Activating miRNA-mRNA network in gemcitabine-resistant pancreatic cancer cell associates with alteration of memory CD4+ T cells
- (2020) Jianyou Gu et al. Annals of Translational Medicine
- Cytotoxic CD4+ T Cells in Bladder Cancer—A New License to Kill
- (2020) Adrian G. Sacher et al. CANCER CELL
- CDKN2A inhibits cell proliferation and invasion in cervical cancer through LDHA-mediated AKT/mTOR pathway
- (2020) Y. Luan et al. Clinical & Translational Oncology
- Inflammation accelerates copper‐mediated cytotoxicity through induction of six‐transmembrane epithelial antigens of prostate 4 expression
- (2020) Cen Jiang et al. IMMUNOLOGY AND CELL BIOLOGY
- The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer
- (2019) Courèche Kaderbhaï et al. Cancers
- Multi-omics profiling reveals distinct microenvironment characterization and suggests immune escape mechanisms of triple-negative breast cancer
- (2019) Yi Xiao et al. CLINICAL CANCER RESEARCH
- TISIDB: an integrated repository portal for tumor-immune system interactions
- (2019) Beibei Ru et al. BIOINFORMATICS
- Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
- (2019) Yingyao Zhou et al. Nature Communications
- Recent Progress in Ferroptosis Inducers for Cancer Therapy
- (2019) Chen Liang et al. ADVANCED MATERIALS
- Targeted Therapies for Triple-Negative Breast Cancer
- (2019) Tomas G. Lyons CURRENT TREATMENT OPTIONS IN ONCOLOGY
- CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer
- (2018) Stephan Bartels et al. JOURNAL OF PATHOLOGY
- Inhibition of breast cancer cell growth by the combination of clofarabine and sulforaphane involves epigenetically mediated CDKN2A upregulation
- (2018) Katarzyna Lubecka et al. NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
- Precision Lasso: Accounting for Correlations and Linear Dependencies in High-Dimensional Genomic Data
- (2018) Haohan Wang et al. BIOINFORMATICS
- TRIM59 overexpression correlates with poor prognosis and contributes to breast cancer progression through AKT signaling pathway
- (2018) Yunxiao Liu et al. MOLECULAR CARCINOGENESIS
- CDKN2A/P16INK4A variants association with breast cancer and their in-silico analysis
- (2018) Ayesha Aftab et al. Breast Cancer
- Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
- (2018) Y -P Chen et al. ANNALS OF ONCOLOGY
- Organoid Modeling of the Tumor Immune Microenvironment
- (2018) James T. Neal et al. CELL
- COSMIC: the Catalogue Of Somatic Mutations In Cancer
- (2018) John G Tate et al. NUCLEIC ACIDS RESEARCH
- Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance
- (2017) Susanne Horn et al. JNCI-Journal of the National Cancer Institute
- NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
- (2017) Delin Chen et al. MOLECULAR CELL
- GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
- (2017) Zefang Tang et al. NUCLEIC ACIDS RESEARCH
- The human protein atlas: A spatial map of the human proteome
- (2017) Peter J. Thul et al. PROTEIN SCIENCE
- Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade
- (2017) Pornpimol Charoentong et al. Cell Reports
- Tumor CDKN2A-Associated JAK2 Loss and Susceptibility to Immunotherapy Resistance
- (2017) Susanne Horn et al. JNCI-Journal of the National Cancer Institute
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
- (2017) Darshan S. Chandrashekar et al. NEOPLASIA
- Copper toxicology, oxidative stress and inflammation using zebrafish as experimental model
- (2016) Talita Carneiro Brandão Pereira et al. JOURNAL OF APPLIED TOXICOLOGY
- Dendritic cell–derived exosomes for cancer therapy
- (2016) Jonathan M. Pitt et al. JOURNAL OF CLINICAL INVESTIGATION
- Lapatinib-loaded human serum albumin nanoparticles for the prevention and treatment of triple-negative breast cancer metastasis to the brain
- (2016) Xu Wan et al. Oncotarget
- Lapatinib inhibits CIP2A/PP2A/p-Akt signaling and induces apoptosis in triple negative breast cancer cells
- (2016) Chun-Yu Liu et al. Oncotarget
- Pathway-Based Genomics Prediction using Generalized Elastic Net
- (2016) Artem Sokolov et al. PLoS Computational Biology
- MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data
- (2015) Alexander Koch et al. BMC GENOMICS
- Robust enumeration of cell subsets from tissue expression profiles
- (2015) Aaron M Newman et al. NATURE METHODS
- Copper activates HIF-1α/GPER/VEGF signalling in cancer cells
- (2015) Damiano Cosimo Rigiracciolo et al. Oncotarget
- FastRFunctions for Robust Correlations and Hierarchical Clustering
- (2015) Peter Langfelder et al. Journal of Statistical Software
- Bleomycin-induced mutagen sensitivity, passive smoking, and risk of breast cancer in Chinese women: a case–control study
- (2013) Mingbai Hu et al. CANCER CAUSES & CONTROL
- Copper toxicity induced hepatocerebral and neurodegenerative diseases: An urgent need for prognostic biomarkers
- (2013) Amit Pal NEUROTOXICOLOGY
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Inferring tumour purity and stromal and immune cell admixture from expression data
- (2013) Kosuke Yoshihara et al. Nature Communications
- CellMiner: A Web-Based Suite of Genomic and Pharmacologic Tools to Explore Transcript and Drug Patterns in the NCI-60 Cell Line Set
- (2012) W. C. Reinhold et al. CANCER RESEARCH
- Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
- (2012) Wanjuan Yang et al. NUCLEIC ACIDS RESEARCH
- Association of RB/p16-Pathway Perturbations with DCIS Recurrence
- (2011) Agnieszka K. Witkiewicz et al. AMERICAN JOURNAL OF PATHOLOGY
- Triple negative breast cancers: Clinical and prognostic implications
- (2009) S.J. Dawson et al. EUROPEAN JOURNAL OF CANCER
- Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
- (2009) David A. Barbie et al. NATURE
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search